<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Villa E</submitter><funding>LAM Foundation</funding><funding>Tuberous Sclerosis Alliance</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>2076-2093.e9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8141029</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>81(10)</volume><pubmed_abstract>The mechanistic target of rapamycin complex 1 (mTORC1) regulates metabolism and cell growth in response to nutrient, growth, and oncogenic signals. We found that mTORC1 stimulates the synthesis of the major methyl donor, S-adenosylmethionine (SAM), through the control of methionine adenosyltransferase 2 alpha (MAT2A) expression. The transcription factor c-MYC, downstream of mTORC1, directly binds to intron 1 of MAT2A and promotes its expression. Furthermore, mTORC1 increases the protein abundance of Wilms' tumor 1-associating protein (WTAP), the positive regulatory subunit of the human N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) RNA methyltransferase complex. Through the control of MAT2A and WTAP levels, mTORC1 signaling stimulates m&lt;sup>6&lt;/sup>A RNA modification to promote protein synt</pubmed_abstract><journal>Molecular cell</journal><pubmed_title>mTORC1 stimulates cell growth through SAM synthesis and m&lt;sup>6&lt;/sup>A mRNA-dependent control of protein synthesis.</pubmed_title><pmcid>PMC8141029</pmcid><funding_grant_id>K08 HL128867</funding_grant_id><funding_grant_id>R00 CA194192</funding_grant_id><funding_grant_id>R01 HL149883</funding_grant_id><funding_grant_id>P30 CA060553</funding_grant_id><funding_grant_id>R01 GM135587</funding_grant_id><funding_grant_id>R01 GM143334</funding_grant_id><funding_grant_id>P01 CA120964</funding_grant_id><pubmed_authors>Helmin KA</pubmed_authors><pubmed_authors>Gao P</pubmed_authors><pubmed_authors>Ben-Sahra I</pubmed_authors><pubmed_authors>Asara JM</pubmed_authors><pubmed_authors>Singer BD</pubmed_authors><pubmed_authors>Villa E</pubmed_authors><pubmed_authors>Sahu U</pubmed_authors><pubmed_authors>O'Hara BP</pubmed_authors><pubmed_authors>Ali ES</pubmed_authors></additional><is_claimable>false</is_claimable><name>mTORC1 stimulates cell growth through SAM synthesis and m&lt;sup>6&lt;/sup>A mRNA-dependent control of protein synthesis.</name><description>The mechanistic target of rapamycin complex 1 (mTORC1) regulates metabolism and cell growth in response to nutrient, growth, and oncogenic signals. We found that mTORC1 stimulates the synthesis of the major methyl donor, S-adenosylmethionine (SAM), through the control of methionine adenosyltransferase 2 alpha (MAT2A) expression. The transcription factor c-MYC, downstream of mTORC1, directly binds to intron 1 of MAT2A and promotes its expression. Furthermore, mTORC1 increases the protein abundance of Wilms' tumor 1-associating protein (WTAP), the positive regulatory subunit of the human N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) RNA methyltransferase complex. Through the control of MAT2A and WTAP levels, mTORC1 signaling stimulates m&lt;sup>6&lt;/sup>A RNA modification to promote protein synt</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2026-05-31T02:10:04.042Z</modification><creation>2025-02-18T23:32:20.945Z</creation></dates><accession>S-EPMC8141029</accession><cross_references><pubmed>33756106</pubmed><doi>10.1016/j.molcel.2021.03.009</doi></cross_references></HashMap>